Table 1.
Characteristics of the whole cohort, and the model building and validation subsets
|
Total (n = 73047) |
Model building (n = 36523) |
Validation set (n = 36524) |
|
|---|---|---|---|
| Age (years) |
41.73 ± 8.38 |
41.7 ± 8.4 |
41.7 ± 8.4 |
| Gender (M/F) |
44118/28929 |
22034/14489 |
22084/14440 |
| Total cholesterol (mg/dL) |
195.17 ± 33.79 |
195.12 ± 33.89 |
195.22 ± 33.70 |
| TG (mg/dL) |
127.55 ± 86.80 |
127.40 ± 86.25 104(73,156) |
127.70 ± 87.34 105 (73,156) |
| HDLc (mg/dL) |
55.20 ± 12.73 |
55.19 ± 12.73 |
55.20 ± 12.74 |
| LDLc (mg/dL) |
110.63 ± 29.43 |
110.62 ± 29.48 |
110.64 ± 29.37 |
| ApoB100 (mg/dL) |
97.52 ± 23.97 |
97.53 ± 24.04 |
97.50 ± 23.0 |
| BMI (kg/m2) | 23.63 ± 3.12 | 23.64 ± 3.12 | 23.63 ± 3.11 |
Data are expressed as mean ± SD or median [interquartile range], unless indicated otherwise. TG: triglyceride, HDLc: High density lipoprotein cholesterol, LDLc: low density lipoprotein cholesterol, Apo B100: apolipoprotein B100, BMI: body mass index.